Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2015 17:16 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Expands Rare Disease Portfolio With the Acquisition of Quinsair(TM)

First Inhaled Fluoroquinolone Therapy for Patients with Cystic Fibrosis Approval Received in the European Union and Canada Expansion of Pipeline with Multiple Late-Stage Orphan Indication...
August 17, 2015 07:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Receives FDA Approval of Expanded Label for PROCYSBI(R) to Treat Children Aged 2-6 Years With Nephropathic Cystinosis

NOVATO, Calif., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (NASDAQ:RPTP) today announced that the U.S. Food and Drug Administration (FDA) approved the expanded use of PROCYSBI®...
August 06, 2015 16:04 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Reports Second Quarter 2015 Financial Results and Provides Corporate Update

PROCYSBI® Product Sales Increased 43% Year over Year to $23.3 Million in Second Quarter Balance Sheet Strengthened with over $220 Million in Cash, Cash Equivalents and Short-Term Investments...
July 30, 2015 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Second Quarter 2015 Financial Results Conference Call and Webcast on Thursday, August 6, 2015, at 4:30 p.m. EDT

NOVATO, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release second quarter 2015 financial results on Thursday, August 6,...
May 28, 2015 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Participate in Upcoming Investor Conferences

NOVATO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Julie Anne Smith, President and Chief Executive Officer, will present at the following...
May 07, 2015 16:04 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports First Quarter 2015 Financial Results and Provides Corporate Update

Reports PROCYSBI® Sales of $20.5 Million in First Quarter Company to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30 p.m. PT NOVATO, Calif., May 7, 2015 (GLOBE NEWSWIRE) --...
May 06, 2015 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference

NOVATO, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference: Julie Anne Smith, President and Chief...
April 30, 2015 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold First Quarter 2015 Financial Results Conference Call and Webcast on Thursday, May 7, 2015 at 4:30 p.m. EDT

NOVATO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release first quarter 2015 financial results on Thursday, May 7, 2015...
April 23, 2015 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Host Investor Day on April 30, 2015

NOVATO, Calif., April 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) will host an Investor Day on Thursday, April 30, 2015, from 8:30 a.m. to 12:00 p.m. EDT (5:30 a.m. to 9:00...
April 08, 2015 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Attend Upcoming Conference

NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Krishna Polu, M.D., Chief Medical Officer, will be a speaker at the following...